Viewing nowMirtazapine 30 mg (Mirtazapine)
Mirtazapine 30mg
Tablet · Prescription medication
MyungIn Pharmaceutical Co., Ltd.

MFDS item code 201404690 · Approved 2014.10.13 · Insurance code 651904090
Treatment of major depressive disorder
This medication is used for major depressive disorder. Major depressive disorder is characterized by persistent feelings of sadness and decreased motivation. This medication helps relieve symptoms and improves the daily life of patients.
The therapeutic dose of this medicine should be adjusted according to the patient's clinical condition, and the lowest effective dose possible should be administered. Adults: The initial dose of mirtazapine is 15mg per day, and the dose may need to be increased until an appropriate clinical effect is achieved. The usual effective daily dose of this medicine is 15 ~ 45 mg. Clearance of this medicine may be reduced in patients with moderate to severe renal impairment (creatinine clearance < 40 mL/min); use caution when prescribing. Clearance of this medicine may be reduced in patients with hepatic impairment; use caution when prescribing. In particular, use caution when prescribing to patients with severe hepatic impairment, as they have not been studied. Older adults: The recommended dose is the same as for adults. When increasing the dose, careful monitoring is needed to obtain a satisfactory and safe effect. The half-life of this medicine is 20 ∼ 40 hours, so once-daily administration is sufficient; if possible, take it at a consistent time in the evening before bedtime. This medicine may also be taken as the daily dose divided equally into two doses, one in the morning and one in the evening. To allow sufficient time to evaluate the therapeutic response to the dose, do not change the dose at intervals of less than 1 ∼ 2 weeks. With an appropriate dose, a therapeutic effect appears within 2∼ 4 weeks. If the effect is insufficient, the dose may be increased up to the maximum dose. If there is no effect after continuing treatment for an additional 2 ∼ 4 weeks, discontinue treatment. Treatment should continue for at least 4 ∼ 6 months until the patient's symptoms have completely resolved. Thereafter, gradual discontinuation is recommended to avoid withdrawal symptoms. Take this medicine orally with water. Swallow it without chewing.
Children and adolescents under 18 years: Do not use this medicine in children or adolescents under 18 years of age, because its efficacy has not been established in two short-term clinical trials and there are safety concerns.
This medication is an antidepressant used to treat major depressive disorder. When taking this medication, there may be an increased risk of suicidal thoughts or behavior, particularly in young adults and adolescents aged 18 to 24, who should be monitored closely. This medication may reduce the number of granulocytes in the blood, increasing the risk of infection; therefore, immediate consultation with a doctor is needed if any symptoms such as a sore throat or fever occur. Patients with impaired liver or kidney function may require dose adjustment and careful monitoring when taking this medication. Drowsiness or dizziness can frequently occur during treatment, so caution should be exercised when driving or operating machinery. This medication may lead to increased appetite and weight gain, so it is advisable to regularly monitor weight changes. Abnormalities may appear on liver function tests, so regular liver function testing is necessary. Care should be taken when using this medication in conjunction with other serotonergic drugs, as it may result in life-threatening serotonin syndrome. Pregnant or breastfeeding women are strongly advised to consult a physician before taking this medication. It is not recommended for use in children and adolescents as the safety and efficacy have not been adequately established. Severe side effects can occur with overdose, so the prescribed dosage must be strictly adhered to. Many medications can interact with this drug, so if you are taking other medications, be sure to inform your physician. If symptoms such as anxiety, agitation, aggression, or insomnia occur during treatment, immediate consultation with a physician is necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container protected from light and air, and kept at a cool temperature between 2°C and 30°C, avoiding humid areas. By storing it this way, the effectiveness of the medication can be safely maintained.
Brownish-red oval film-coated tablet
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMirtazapine 30mg
Tablet · Prescription medication
MyungIn Pharmaceutical Co., Ltd.

Mirtazapine 15mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Mirtazapine 30mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Mirtazapine
Prescription medication
Korea Novartis Co., Ltd.

Mirtazapine 30mg
Orally disintegrating Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Mirtazapine 15mg
Tablet · Prescription medication
SamIl Pharmaceutical Co., Ltd.

Mirtazapine 30mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Mirtazapine 15mg
Orally disintegrating Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.